Fluorescence In-Situ Hybridization Imaging Systems Market Overview 2022

The global fluorescence in-situ hybridization (fish) imaging systems market size was valued at USD 889 million in 2021, growing at a CAGR of 8.0% during the forecast period 2022-2028. FISH (fluorescence in situ hybridization) is a cytogenetic technique that uses fluorescent chromosome probes to indicate a high degree of sequence complementarity. To determine where the fluorescent sensor is linked to the chromosome, fluorescence microscopy is utilized. This technology allows researchers to visualize and characterize the genetic material in an individual cells, particularly specific genes or sections of genes, in a novel way. FISH is an important method for diagnosing chromosomal abnormalities as well as other genetic alterations.

 
 View detailed report description here https://precisionbusinessinsights.com/market-reports/fluorescence-in-situ-hybridization-fish-imaging-systems-market/ 

The rise in the prevalence of target diseases creates a clinical need for quick diagnostic options like Fluorescence In Situ Hybridization (FISH) imaging technologies, which is expected to drive growth over the coming years. Additionally, growing understanding of the system's related benefits, such as rapid analysis, improved visualization, high precision of results, and a broad range of applications, is one of the primary factors driving adoption. In the field of in-vitro diagnostics, technologically advanced products are also driving the market. For example, one of the significant advances responsible for increased demand for FISH imaging equipment is the introduction of 3D FISH technology. It allows for three-dimensional imaging and analysis of target cells, increasing the likelihood of successful study outcomes. Positive research outcomes, shorter procedure times, ease of use, and higher probe labelling efficiency are just a few of the advantages of using FISH imaging, which is predicted to drive up demand. Furthermore, combining FISH imaging equipment with other sophisticated technologies, also including high-throughput automated imaging systems and software, to provide faster, more efficient, and clear results, is predicted to boost growth over the coming years. This is also expected to open up new possibilities for research applications.

The global fluorescence in-situ hybridization (fish) imaging systems market segmentation:
 1) By Product Type: Consumables, Instruments, Software. 
 2) By Application Type: Cancer Diagnostics, Cytology, Infectious Disease Diagnostics, Neuroscience, Immunology and Others. 
 3) By Technology: DNA FISH, RNA FISH, PNA FISH, CISH. 
 4) By End Users: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations.

Request sample report https://precisionbusinessinsights.com/request-sample?product_id=64212       

Due to the obvious increasing incidence of chronic disease and increasing product approvals connected to FISH, North America is likely to be a dominating region in the fluorescence in situ hybridization market. For example, Oxford Gene Technology gained FDA (Food and Drug Administration) permission in 2019 for eight fish probes that will be used to identify acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS). As per the American Cancer Society, the number of people diagnosed with cancer in 2020 will be 1.7 million. As a result, the fluorescent in situ hybridization market is predicted to develop.
 

some of the major players key players in the global fluorescence in-situ hybridization (fish) imaging systems market, Leica BiosystemsNussloch GmbH, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Thorlabs, Inc., General Electric Company, COM, Bio-Rad Laboratories, Inc.,, BioTek Instruments, Inc., MetaSysems, Applied Spectral Imaging, Clinx Science Instruments Co., Ltd.

About Precision Business Insights:  
 We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553 ​
​Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747